|SCHEDULE 13D/AAug 15, 4:54 PM ET

X4 Pharmaceuticals, Inc SCHEDULE 13D/A

SCHEDULE 13D/A · Growth Equity Opportunities 18 VGE, LLC · Filed Aug 15, 2025

Documents

3 files
  • SCHEDULE
    primary_doc.xml
  • EX-1

    AGREEMENT REGARDING FILING OF JOINT SCHEDULE 13D

  • EX-2

    POWER OF ATTORNEY REGARDING FILINGS UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED